HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Wednesday, 25 January 2017

Cochrane Collaboration Issue 1, 2017…

….is almost complete, but I’m off to Berlin, so you’re getting it now :)  The website lists protocols and methodology papers as well, but we’ll just flag up the notable reviews; these being……
  • Beta‐blockers for hypertension
  • First‐line combination therapy versus first‐line monotherapy for primary hypertension
  • Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysm
  • Fulvestrant for hormone‐sensitive metastatic breast cancer
Image: B0008351 Beta blocker crystals by Wellcome Images




Posted by at